Gut Microbiota and the Gut–Liver Axis in Liver Disease: From Chronic Viral Hepatitis to Cirrhosis, Hepatocellular Carcinoma, and Microbiome-Based Therapies
Chronic viral hepatitis B and C remain major global health challenges, contributing significantly to liver-related morbidity and mortality. Despite antiviral therapies and vaccines for HBV, progression to cirrhosis and hepatocellular carcinoma remains common. For HCV, the lack of a vaccine and high...
Saved in:
| Main Authors: | Sniedze Laivacuma, Olga Oblate, Aleksejs Derovs |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Microorganisms |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-2607/13/5/1053 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unveiling the distinctive gut microbiota and metabolites in liver cirrhosis and its complications: Novel diagnostic biomarkers: Editorial on “Gut microbiome and metabolome signatures in liver cirrhosis-related complications”
by: Soon Kyu Lee, et al.
Published: (2025-01-01) -
Liver cirrhosis as a result of chronic hepatitis C
by: A. A. Sukhoruk, et al.
Published: (2014-09-01) -
Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease
by: Samradhi Singh, et al.
Published: (2024-09-01) -
Morphological changes in the brain in liver cirrhosis of alcoholic and viral etiology
by: A. M. Maybogin, et al.
Published: (2022-12-01) -
Sarcopenia in chronic liver disease, can we predict complications?
by: U. R. Salimov, et al.
Published: (2022-12-01)